Home / Science / New Dog Pill Aims to Extend Canine Lifespan
New Dog Pill Aims to Extend Canine Lifespan
9 Apr
Summary
- Experimental drug LOY-002 targets IGF-1 hormone in aging dogs.
- The pill aims to slow cellular aging and extend dog lifespans.
- The drug is undergoing FDA review and is close to market.
An experimental daily pill named LOY-002, developed by biotech firm Loyal, shows promise in extending the lifespan of senior dogs. This drug is designed for dogs aged 10 and older, particularly those weighing over 14 pounds. It functions by targeting the Insulin-Like Growth Factor 1 (IGF-1) hormone, which influences growth and metabolism.
While IGF-1 is essential for puppy development, it is also associated with accelerated cellular aging in mature dogs. LOY-002 is intended to directly address this aging process, potentially adding years to a dog's life. The drug has successfully completed two of the three required stages for approval by the US Food and Drug Administration, moving closer to its market release.
Despite the ongoing development of LOY-002, veterinarians continue to emphasize the importance of established methods for maintaining senior dogs' health. These include regular veterinary checkups, a balanced diet, and appropriate exercise tailored to the dog's age and condition. Consulting with a veterinarian is also advised before making significant lifestyle changes or introducing new supplements, especially for dogs with chronic health issues.
